|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||5.08 - 5.40|
|52 Week Range||3.00 - 7.27|
|Beta (3Y Monthly)||1.31|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.23|
NEW YORK and TORONTO , April 18, 2019 /PRNewswire/ - iAnthus Capital Holdings, Inc . ("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class ...
iAnthus Capital (ITHUF) embodies the top themes in the cannabis sector this year. The company is a relatively unknown player outside cannabis insiders focused on the U.S. with quarterly results on the verge of hitting an inflection point. Not to mention, the stock has a future catalyst of transitioning to a major U.S. exchange as cannabis likely becomes approved on a Federal basis in the future.Growing Up FastiAnthus just reported Q4 results that wouldn’t impress many investors. The company only generated $2.2 million in revenues giving the impression that the relatively unknown company should remain that way.In reality, iAnthus is a U.S. multi-state operator (MSO) that just entered their 10th state. The company had pro-forma revenues of $14.8 million in the quarter or an annual runrate of $60 million already. The acquisition of MPX that closed in February added revenue from their Colorado and New Mexico operations.Due to acquisitions, iAnthus opened dispensaries in Boston, Brooklyn, Baltimore and West Palm Beach. The company has 21 dispensaries open with a footprint potential of 68 dispensaries.The company didn’t provide a lot of details on the pro-forma results outside of revenues so investors will want to keenly focus on these numbers as 2019 results roll out.Relative ValueThe U.S. cannabis company has a market value of $1.3 billion that offers interesting relative value compared to the Canadian players highly focused on being farmers. One big key is that iAnthus is quickly buying actual operations and quickly developing U.S. markets versus global expansion that isn’t ready for primetime yet.iAnthus enters 2019 with access to 11 states with 121 million people and a predicted market size of $10 billion. This compares to a total Canadian population of approximately 38 million people.Source: iAnthus Capital April presentation In addition, most American companies aren’t going full force into the cultivation and processing part of the business. iAnthus has a current footprint of 200,000 square feet with an additional 380,000 square feet of planned expansion.As a comparison, Aurora Cannabis (ACB) recently announced the intent to expand one facility alone from 1.2 million square feet to 1.6 million square feet. The large Canadian cannabis company has 13 additional cultivation facilities that far exceed the 580,000 square feet of iAnthus Capital.The future will tell which plan was the right one, but iAnthus doesn’t face a scenario of having far too much supply for current demand. While the Canadian players are producing far in excess of the local demand requiring a leap of faith that global demand will absorb some of the excess production.TakeawayThe key investor takeaway is that companies like iAnthus Capital are underappreciated by the stock market. The company is quickly growing into a large MSO in the U.S. with plenty of opportunity for expansion and additional acquisitions to expand into further states as the market opens up.A big differentiator among the U.S. MSOs will turn to a focus on operational efficiency and growth potential. Investors should stay tuned as the story develops in the U.S. where the companies are mostly under the radar. The general market focus on the large Canadian players that locked themselves out of the booming U.S. market is an advantage to small investors paying attention to this market dynamic.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Disclosure: The author has no position in ITHUF. The information contained herein is for informational purposes only. More recent articles from Smarter Analyst: * Jeff Bezos Is Leading Amazon (AMZN) in the Right Direction * Why Autonomous Could Be a Strong Driver for Nvidia (NVDA) Stock * Microsoft (MSFT) Stock's Big Rally Should Continue * Oppenheimer Still Sees 40% Upside for Tesla (TSLA) Stock
("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to announce Neil Calvesbert as Chief Marketing Officer responsible for creating the brand vision and strategies to execute the companies growth objectives across brand, retail and consumer experience. Prior to joining iAnthus, Mr. Calvesbert served as the Chief Growth & Marketing Officer for Nicopure Labs and the Vice President of Global Marketing for Monster Energy Beverages, where he leveraged the Monster Energy brand to deliver inspirational brand stories and lifestyle-focused experiences through strategic partnerships with high profile athletes, musicians, influencers, global properties and events with a disruptive approach.
Benzinga is all geared up to host its third rendition of the Cannabis Capital Conference , full of big-time investors, top industry executives and reporters from around the world. If you haven’t already ...
CORAL GABLES, FL / ACCESSWIRE / April 11, 2019 / When speaking about the marijuana stock market, we cannot help but bring the Canadian cannabis industry into the conversation. For quite some time, Canada has been leading the global charge in terms of advocating in favor of cannabis legalization. Although cannabis growers are typically the companies most people focus on, it would seem that there are a significant amount of companies with ancillary functions in the cannabis sector.
NEW YORK and TORONTO , April 11, 2019 /PRNewswire/ - iAnthus Capital Holdings, Inc . ("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class ...
Planet 13 and Wayland Group Posted Strong Performance Last Week(Continued from Prior Part)Stock performance Cannabis stocks were mixed last week. Of the seven companies considered for our analysis in this article, three have given positive returns,
The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress. “Many of these combined companies feel they can be stronger competitors if they are bigger players.
Canadian cannabis company iAnthus Capital Holdings Inc (OTC: ITHUF) announced Thursday that its U.S. subsidiary is entering into a licensing agreement with Blissiva, a medical cannabis company focused on products developed specifically for women.
("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States , is pleased to announce a licensing agreement entered into between its U.S. subsidiary and Blissiva, a women-owned, Maryland -based company specializing in producing and distributing medical cannabis products specifically formulated for women. As per the licensing agreement, iAnthus will manufacture, market and sell a variety of Blissiva products in its markets, with initial launch in Maryland scheduled for April 20, 2019 .
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) has announced that its U.S based subsidiary has entered an interim agreement for the acquisition of national CBD brand CBD For Life. Growing Interest for CBD For Life from retailers Following the enactment of the 2018 Farm Bill, the company has seen an influx of interest from various mainstream retailers […]The post iAnthus Capital To Acquire CBD For Life appeared first on Market Exclusive.
Analyzing iAnthus Capital Holdings’ Q4 Results(Continued from Prior Part)Stock performance After iAnthus Capital Holdings (ITHUF) (IAN) posted its fourth-quarter earnings on April 2, the company’s stock price rose and closed the day at 7.61
Analyzing iAnthus Capital Holdings’ Q4 ResultsFourth-quarter results On April 2, iAnthus Capital Holdings (ITHUF) (IAN) posted its fourth-quarter earnings before the market opened. For the quarter ending on December 31, the company posted
Vancouver-based cannabis company iAnthus Capital Holdings Inc (OTC: ITHUF) reported fourth-quarter financial results Tuesday, including pro forma revenue of $14.8 million. The pro forma revenue figure includes MPX Bioceutical Corporation entities that iAnthus agreed to acquire in October — the deal closed in February — as well as managed revenue for Colorado and New Mexico operations.
("iAnthus" or the "Company") (CSE: IAN, OTCQX: ITHUF), which owns, operates, and partners with best-in-class regulated cannabis operations across the United States, is pleased to report its unaudited financial results for the fiscal fourth quarter and year ended December 31, 2018.
The cannabis world received mixed news last week. On the one hand, the House Financial Services Committee voted in favor of a bill that would allow marijuana businesses to work with banks and credit unions, the SAFE Banking Act, allowing it to advance to the House floor. On the other hand, the state of New Jersey cancelled its vote on a bill that would legalize recreational cannabis due to a lack of support from legislators.